Finn Patrick John's Form 4 filing
Twist Bioscience Corp (TWST) · filed Feb 19, 2026
- Accession no.
- 0001214659-26-002179
- Filed
- Feb 19, 2026
- Trade date
- Feb 17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.56M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finn Patrick JohnCIK 0001755970 | Officer (President and COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +18,205 | $23.33 | +$424,722.65 | 324,455 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +32,300 | $26.66 | +$861,118 | 356,755 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −21,858 | $50.32 | −$1,099,894.56 | 334,897 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −16,616 | $51.42 | −$854,394.72 | 318,281 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −26,952 | $52.69 | −$1,420,100.88 | 291,329 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −3,541 | $53.11 | −$188,062.51 | 287,788 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −32,300 | $0.00 | $0 | 0 | Direct | |
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −18,205 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.